Evolent Health, Inc.

NYSE:EVH

Medical - Healthcare Information Services

Healthcare
$3.93 -6.00%

-$0.28 today

Market cap
$442.05M
Beta
0.83
P/E (TTM)
-1.0
EPS (TTM)
-$4.44
52W Low $2.10High $12.07

Volume 3.10M

Average 2.78M

EVH Accumulated OCI

Accumulated other comprehensive income: unrealized gains and losses, such as currency translation, recorded outside net income.

Evolent Health, Inc.NYSE: EVH

Accumulated OCI · Q1 FY2026 · quarter ended Mar 2026

Accumulated OCI remains negative

Q1 FY2026 Accumulated OCI was -$3.63M, compared with -$1.73M a year earlier.

Context

  • Accumulated OCI amounted to 0.2% of total assets at the end of Q1 FY2026, up 0.1 pp from a year earlier.
  • Accumulated OCI grew in size in 3 of the last 3 fiscal years.
  • FY2025 was the largest annual figure in the 4 fiscal years shown.

What to watch

Whether Accumulated OCI keeps falling in the next quarterly balance sheet after a -109.7% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$3.63M-38.2% QoQ
Last fiscal yearDec 2025
-$2.62M-49.7% YoY
Year agoMar 2025
-$1.73M-109.7% since
Accumulated OCI past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-109.7%——
1 year-49.7%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Accumulated OCI history

USD · from the balance sheet

Latest · FY2025
(2.62M) USD
Year-over-year change
-49.7%

Accumulated OCI vs competitors

How EVH compares with its peers on the latest reported figures

  • EVH's Mar 2026 Accumulated OCI of -$3.63M is the lowest of the 11 companies compared; the peer median is $0.
  • Its year-over-year change of -109.7% is the 6th highest of 9, against a peer median of +6.4%.
  • Accumulated OCI amounts to 0.2% of total assets for EVH, versus a peer median of 0.1%.
EVH Competitors Peer median
Accumulated OCI for EVH and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
REPLReplimune Group, Inc.Dec 2025$5.56M -9.7%—1.7%
MGTXMeiraGTx Holdings plcMar 2026$2.58M +150.9%-26.4%1.1%
MYGNMyriad Genetics, Inc.Mar 2026$700K +216.7%—0.1%
AMNAMN Healthcare Services, Inc.Mar 2026$113K +126.0%—0.0%
BFLYButterfly Network, Inc.Mar 2026$0 ——0.0%
NUTXNutex Health, Inc.Mar 2026$0 ——0.0%
PSNLPersonalis, Inc.Mar 2026-$70K -288.9%—0.0%
AVBPArriVent BioPharma, Inc. Common StockMar 2026-$270K -1488.2%—0.1%
KURAKura Oncology, Inc.Mar 2026-$380K -139.0%—0.1%
HSTMHealthStream, Inc.Mar 2026-$1.57M +22.4%—0.3%
EVHEvolent Health, Inc.Mar 2026-$3.63M -109.7%—0.2%
Peer median (excluding EVH) $0+6.4%-26.4%0.1%

Competitors are the stored peer set for EVH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents266.28M188.2M192.83M104.2M151.86M
Short-term Investments00059.3M0
Net Receivables130.6M254.68M446.75M414.68M323.4M
Inventory00000
Other Current Assets75.69M35.17M44.1M28.94M31.12M
Total Current Assets523.96M478.05M683.67M607.12M506.37M
Property, Plant & Equipment (Net)131.57M136.9M90.18M79.29M85.16M
Goodwill426.3M722.77M1.12B1.14B694.48M
Intangible Assets279.78M442.78M752.01M680.16M584.94M
Long-term Investments5.46M4.48M4.9M8.59M8.97M
Tax Assets00000
Other Non-current Assets52.39M32.31M33.01M31.95M19.32M
Total Non-current Assets895.5M1.34B2B1.94B1.39B
Total Assets1.42B1.82B2.68B2.54B1.9B
Account Payables96.08M57.17M48.25M96.03M59.78M
Short-term Debt000171.47M0
Tax Payables00000
Deferred Revenue11.94M5.76M5.98M2.51M1.2M
Other Current Liabilities223.16M252.19M460.43M352.42M243.18M
Total Current Liabilities445.49M433.44M674.24M715.5M385.26M
Long-term Debt215.68M412.99M597.05M490.52M970.54M
Deferred Tax Liabilities1.4M50.69M121.24M119.01M7.51M
Deferred Revenue (Non-current)0000110K
Other Non-current Liabilities5.53M4.74M182.06M193.16M116.81M
Total Non-current Liabilities280.33M524.43M938.37M827.65M1.1B
Total Liabilities725.83M957.88M1.61B1.54B1.48B
Common Stock908K1.02M1.15M1.17M1.18M
Retained Earnings(626.78M)(606.15M)(719.19M)(780.82M)(1.32B)
Accumulated OCI(362K)(1.18M)(1.26M)(1.75M)(2.62M)
Other Stockholders Equity00000
Minority Interest00000
Total Equity693.63M859.42M1.07B1B415.19M
Total Debt280.47M476.12M644.8M713.67M989.7M
Net Debt14.19M287.92M451.97M609.47M837.84M

Evolent Health, Inc.

NYSE:EVH

Intrinsic Alpha fair value

Locked

Current Price

$3.93

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.